Prospects of Directly Reprogrammed Adult Human Neurons for Neurodegenerative Disease Modeling and Drug Discovery: iN vs. iPSCs Models

被引：9

作者：

Zhang, Ying ^{[1
,2
]}

Xie, Xinyang ^{[1
,2
,3
]}

Hu, Jiangnan ^{[4
]}

Afreen, Kazi Sabrina ^{[5
]}

Zhang, Chun-Li ^{[6
]}

Zhuge, Qichuan ^{[1
,2
]}

Yang, Jianjing ^{[1
,2
]}

机构：

[1] Wenzhou Med Univ, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Affiliated Hosp 1, Wenzhou, Peoples R China

[2] Wenzhou Med Univ, Dept Neurosurg, Affiliated Hosp 1, Wenzhou, Peoples R China

[3] South China Normal Univ HFI, Int Dept, Affiliated High Sch, Guangzhou, Peoples R China

[4] Univ North Texas, Hlth Sci Ctr, Dept Pharmaceut Sci, Ft Worth, TX USA

[5] Rosalind Franklin Univ Med & Sci, Dept Microbiol & Immunol, N Chicago, IL USA

[6] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX USA

来源：

FRONTIERS IN NEUROSCIENCE | 2020年 / 14卷

基金：

中国国家自然科学基金;

关键词：

iN; iPSCs; disease modeling; drug screening; neurodegenerative disease; PLURIPOTENT STEM-CELLS; FAMILIAL ALZHEIMERS-DISEASE; AMYOTROPHIC-LATERAL-SCLEROSIS; HUMAN FIBROBLASTS; DIRECT CONVERSION; DOPAMINERGIC-NEURONS; MOTOR-NEURONS; GABAERGIC INTERNEURONS; FUNCTIONAL-NEURONS; GENETIC CORRECTION;

D O I：

10.3389/fnins.2020.546484

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

A reliable disease model is critical to the study of specific disease mechanisms as well as for the discovery and development of new drugs. Despite providing crucial insights into the mechanisms of neurodegenerative diseases, translation of this information to develop therapeutics in clinical trials have been unsuccessful. Reprogramming technology to convert adult somatic cells to induced Pluripotent Stem Cells (iPSCs) or directly reprogramming adult somatic cells to induced Neurons (iN), has allowed for the creation of better models to understand the molecular mechanisms and design of new drugs. In recent times, iPSC technology has been commonly used for modeling neurodegenerative diseases and drug discovery. However, several technological challenges have limited the application of iN. As evidence suggests, iN for the modeling of neurodegenerative disorders is advantageous compared to those derived from iPSCs. In this review, we will compare iPSCs and iN models for neurodegenerative diseases and their potential applications in the future.

引用

页数：11

共 6 条

[1] Using Human iPSCs for Psychiatric Disorder Disease Modeling and Mechanism-Based Drug Discovery
Wen, Zhexing
Guo, Ziyuan
Wang, Xinyuan
Kim, Namshik
Ross, Christopher
Margolis, Russell
Christian, Kimberly
Chen, Gong
Zheng, Wei
Xia, Menghang
Song, Hongjun
Ming, Guo-li
[J]. BIOLOGICAL PSYCHIATRY, 2017, 81 (10) : S290 - S291
[2] Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery
Corti, Stefania
Faravelli, Irene
Cardano, Marina
Conti, Luciano
[J]. EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (06) : 615 - 629
[3] Human Engineered Heart Tissue Models for Disease Modeling and Drug Discovery
Tani, Hidenori
Tohyama, Shugo
[J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
[4] Chemotherapy-Induced Neuropathy and Drug Discovery Platform Using Human Sensory Neurons Converted Directly from Adult Peripheral Blood
Vojnits, Kinga
Mahammad, Saleemulla
Collins, Tony J.
Bhatia, Mickie
[J]. STEM CELLS TRANSLATIONAL MEDICINE, 2019, 8 (11) : 1180 - 1191
[5] 3D human brain cell models: New frontiers in disease understanding and drug discovery for neurodegenerative diseases
Korhonen, Paula
Malm, Tarja
White, Anthony R.
[J]. NEUROCHEMISTRY INTERNATIONAL, 2018, 120 : 191 - 199
[6] Characterization of Robust and Consistent Human iPSC-derived Induced Excitatory Neurons for Disease Modeling and Drug Discovery
Kutsch, A.
Bradley, R. A.
Ma, J.
Fathi, A.
Fiene, R.
Hogan, C.
Carlson, C.
Hilcove, S.
Schachtele, S.
Liu, J.
[J]. TOXICOLOGY LETTERS, 2023, 384 : S193 - S193

← 1 →